EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Comparative phase 2 bioavailability study of a fast acting, dry powder-based, epinephrine intra-nasal formulation, FMXIN002, for anaphylaxis

Sunday 02 Jun, 15:00 PM - 15:12 PM Valencia, Spain